“First visit nerves went away because of kind services. Laser part was my concern but there wasn’t any problem. Pleasant experience.”
Myopic Degeneration: What You Need to Know
Who Is at Risk
Myopic degeneration is more widespread than many people realize, and certain factors increase a person's likelihood of developing the condition. Understanding your risk can help you and your retina specialist decide how closely to monitor your eyes.
Nearsightedness has become increasingly common, with roughly four in ten Americans now affected. High myopia, which carries the greatest risk for retinal complications, affects a smaller proportion of the population. Among people with high myopia, a significant percentage will develop some degree of myopic macular degeneration over their lifetime. The condition is recognized as one of the leading causes of visual impairment both in the United States and globally.
Several factors raise the likelihood that high myopia will progress to myopic degeneration.
- Greater axial length of the eye, meaning a longer distance from front to back
- A stronger myopic prescription, particularly beyond negative 6.00 diopters
- Older age, though degenerative changes can appear in patients as young as their twenties
- A family history of high myopia or myopic degeneration
- East and Southeast Asian descent, populations with the highest documented rates of myopia worldwide
Even if only one eye currently shows signs of the condition, the other eye is also at risk. Research indicates that a substantial portion of patients who develop CNV in one eye will develop it in the other eye within several years. This is why both eyes are monitored carefully at every visit.
Anyone with high myopia should have periodic retinal evaluations, even when vision feels stable and no symptoms are present. Your general eye doctor or optometrist can identify high myopia and refer you for a specialized retinal examination. The earlier any degenerative changes are found, the more options are available for protecting your vision.
Symptoms and Warning Signs
Myopic degeneration does not always announce itself with obvious symptoms, especially early on. Knowing what to watch for, and when to act immediately, can make a real difference in your outcome.
In the early stages, myopic degeneration may cause no noticeable symptoms at all. The thinning and stretching of retinal tissue can be detected on examination before any vision loss occurs. As the condition advances, some people notice a slow decline in their best-corrected vision, meaning vision that does not sharpen up fully even with the right prescription. Colors may appear slightly faded, and fine details may become harder to see.
When CNV develops, symptoms often appear suddenly rather than gradually. A person with myopic CNV may notice a rapid drop in central vision over the course of days or weeks. Straight lines may appear wavy or distorted, a symptom called metamorphopsia. Dark or gray patches, known as scotomas, may appear in the central field of vision. Color perception can also shift noticeably.
Any of these symptoms in a person with high myopia should prompt an urgent visit to a retina specialist. CNV that is caught and treated early offers a better chance of preserving vision than CNV that has been present for some time.
Some symptoms cannot wait for a routine appointment. If you have high myopia and experience any of the following, contact a retina specialist or go to the emergency room right away.
- Sudden loss of vision in one eye
- New distortion where straight lines appear wavy or bent
- A dark or gray spot in the center of your vision
- A sudden large increase in floaters or new flashes of light
- A curtain or shadow spreading across part of your vision
These symptoms may indicate CNV, a retinal tear, or a retinal detachment. All of these are time-sensitive conditions where prompt treatment can prevent permanent vision loss.
How Myopic Degeneration Is Diagnosed
A thorough, specialized eye evaluation is the foundation for diagnosing myopic degeneration and planning appropriate care. Our team uses advanced imaging technology at every visit to track changes over time with precision.
Diagnosis begins with a comprehensive eye exam that includes dilation, which widens the pupil to give the retina specialist a clear view of the back of the eye. During this examination, the specialist looks for signs of stretching, thinning, atrophy, lacquer cracks, and abnormal blood vessels. Refractive error (glasses prescription) is measured, and in some cases axial eye length is measured as well.
Optical coherence tomography (OCT) is a non-invasive imaging test that produces detailed, cross-sectional pictures of the retina. OCT can reveal fluid beneath the retina, changes in retinal layer thickness, and early signs of CNV that might not be visible on direct examination alone. OCT angiography (OCTA) can map retinal blood flow without requiring a dye injection, helping identify abnormal vessels in some cases. Our team uses OCT imaging at every visit to monitor disease activity and guide treatment decisions.
When CNV is suspected, fluorescein angiography may be performed. A yellow dye is injected into a vein in the arm and circulates to the blood vessels of the eye. A specialized camera captures images that highlight leaking or abnormal vessels clearly. Indocyanine green (ICG) angiography is a similar technique using a different dye and is useful for examining deeper layers of the choroid. These imaging tools help the retina specialist confirm the diagnosis and plan treatment precisely.
Treatment Options for Myopic Degeneration
The right treatment depends on which complications are present. Our team tailors care to each patient's specific findings, using proven therapies to protect and preserve vision.
The primary treatment for myopic CNV is anti-VEGF therapy. VEGF stands for vascular endothelial growth factor, a protein in the body that stimulates abnormal blood vessel growth. Anti-VEGF medications block this protein to stop leaking and reduce new vessel formation. These medications are delivered through intravitreal injections, meaning a small injection placed directly into the eye in a clinical setting.
Several anti-VEGF agents are used to treat myopic CNV, including Lucentis (ranibizumab), Eylea (aflibercept), Avastin (bevacizumab), and Vabysmo (faricimab). Biosimilar versions of some of these medications are also available and have received FDA approval, providing additional options for patients and specialists. Myopic CNV tends to respond well to anti-VEGF treatment, often more quickly and with fewer injections than other conditions involving abnormal retinal vessel growth.
A common approach to treating myopic CNV starts with an initial injection followed by close monthly monitoring using vision testing and OCT imaging. Additional injections are given only when signs of active disease return, such as new fluid under the retina or worsening vision. Because myopic CNV responds well in many patients, the total number of injections needed over time is often lower than with other retinal conditions. Regular monitoring remains essential even during quiet periods to catch any recurrence early.
Not all complications of myopic degeneration involve CNV. Retinal tears may be treated with laser photocoagulation, which uses a thermal laser to seal the tear, or cryopexy, a freezing technique that achieves the same result. Retinal detachments may require surgery such as pars plana vitrectomy (a procedure to remove the vitreous gel and repair the retina), scleral buckling (a procedure that supports the wall of the eye), or pneumatic retinopexy (a procedure using a gas bubble to reattach the retina). Macular holes, which can occur in highly myopic eyes, may also require vitrectomy. Our retina specialists recommend the appropriate approach based on each patient's specific situation.
An intravitreal injection is performed in a clinical setting and takes only a few minutes. The eye is numbed with anesthetic drops before the injection, and most patients describe a sensation of pressure rather than sharp pain. Mild redness, a gritty feeling, or temporarily blurry vision afterward are common and usually resolve within a day or two. Serious complications such as infection inside the eye (endophthalmitis) are uncommon but possible. Our team will review all risks and provide detailed post-injection care instructions before and after every treatment.
Living with Myopic Degeneration
Myopic degeneration is a lifelong condition, but with the right care and habits, many people maintain useful vision for decades. There are meaningful steps you can take between appointments to support your eye health.
One of the most practical things you can do between visits is monitor your vision using an Amsler grid, a simple chart made up of a grid of straight lines with a center dot. By covering one eye at a time and looking at the dot, you can check for new distortion, wavy lines, or missing areas in your vision. If anything changes from one day to the next, contact your retina specialist promptly rather than waiting for your next scheduled appointment.
Wearing UV-protective sunglasses outdoors may help shield the retina from additional light-related damage. Safety glasses should be worn during sports or activities where eye injury is a risk. Maintaining a healthy diet that includes leafy green vegetables and omega-3 fatty acids is broadly beneficial for retinal health, and avoiding smoking is strongly advisable. None of these steps reverse existing damage, but they support the overall health of your eyes.
Because high myopia and myopic degeneration have a genetic component, first-degree relatives of affected individuals should have regular comprehensive eye exams. Parents with high myopia should be aware that their children may have an increased risk. In children, early identification of high myopia allows for closer surveillance as they grow, and timely referral to a retina specialist if any degenerative changes appear.
If myopic degeneration has affected your central vision, low vision rehabilitation services can help you make the most of your remaining sight. These services may include magnifying devices, adjusted lighting, large-print materials, and training on adaptive techniques for everyday tasks. Many people with vision loss from this condition continue to live independently and remain active with the right support in place.
Frequently Asked Questions
These answers address common questions patients ask us about living with myopic degeneration and planning their care.
Once high myopia has developed, the structural elongation of the eye cannot be reversed, and there is currently no proven method to prevent myopic degeneration from occurring. However, regular retinal examinations allow a retina specialist to find complications like CNV at their earliest and most treatable stage. Ongoing research into slowing myopia progression in children, including options like low-dose atropine drops and specially designed contact lenses, may reduce long-term risk for future generations, though these are not treatments for established myopic degeneration.
Both conditions involve abnormal blood vessel growth beneath the retina and are treated with anti-VEGF injections, but they are not the same disease. Myopic CNV tends to affect younger patients and is driven by the mechanical stress of an elongated, thinning eye. Wet AMD is primarily an age-related disease associated with the buildup of deposits called drusen under the retina. Myopic CNV also responds more quickly to anti-VEGF treatment in most cases and typically requires fewer total injections over time compared to wet AMD.
No. LASIK and similar procedures reshape the cornea, the clear front surface of the eye, to correct how light is focused. They do not change the physical length of the eye or address the thinning and stretching of retinal tissue that underlies myopic degeneration. A person who has had LASIK to correct their nearsightedness still has an elongated eye and remains at the same risk for retinal complications. Continued monitoring by a retina specialist is just as important after refractive surgery as before it.
Many patients with myopic CNV require only a limited course of injections. Unlike some other retinal conditions where long-term regular treatment is the norm, myopic CNV often responds well to an initial injection or small series of treatments, with recurrences being less frequent. Some patients do need additional injections months or years later if CNV returns. Your retina specialist will evaluate your eyes at each visit and recommend retreatment only when there is evidence of active disease, keeping the total treatment burden as low as possible.
For most patients, wearing contact lenses does not worsen myopic degeneration or directly harm the retina. However, you should always discuss your full eye health picture with your retina specialist and your general eye care provider. If CNV is active or you have recently had treatment, your team may give specific guidance about lens wear during recovery. More broadly, any sudden change in vision while wearing lenses should prompt an immediate call to your retina specialist rather than assuming the lens is the cause.
Untreated CNV can cause rapid and significant damage to the central retina. The abnormal vessels leak fluid and blood into the area responsible for sharp, detailed vision, and this damage can become permanent if the vessels remain active for an extended time. The degree of vision that can be recovered after treatment depends largely on how much injury occurred before treatment began. This is why any sudden vision change, distortion, or new central blind spot in a patient with high myopia should be evaluated urgently rather than observed at home.
See Our Team at Atlantic Retina Center
Our fellowship-trained retina specialists at Atlantic Retina Center are dedicated exclusively to the health of the retina, vitreous, and macula, giving patients across the Delmarva peninsula access to specialized, experienced care close to home. If you have high myopia or have been told you are at risk for retinal complications, we encourage you to schedule an evaluation with our team. Early detection and timely treatment are your strongest tools for preserving your vision for years to come.